FDA Approves Plasma Treatments

“The U.S. Food & Drug Administration (FDA) on Sunday said it authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the disease, a day after President Donald Trump blamed the agency for impeding the rollout of coronavirus vaccines and therapeutics for political reasons.” (Reuters)

A study by the Mayo clinic referenced by the FDA noted that those transfused with higher levels of antibodies were less likely to die (11% died rather than 14%). That means out of 100 patients, an additional three...